Edap Tms (FOCL) EBIT Margin (2009 - 2026)
Edap Tms' (FOCL) quarterly EBIT Margin came in at 41.35% in Q1 2026, up 285.0% YoY from 10.74% in Q1 2025, and down 50.61% on a QoQ basis from 27.46% in Q4 2025.
Edap Tms (FOCL) EBIT Margin (2009 - 2026) Analysis & Trends
Edap Tms (FOCL) has 18 years of EBIT Margin data on file, last reported at 41.35% in Q1 2026.
- Quarterly EBIT Margin rose 285.0% year-over-year to 41.35% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 34.66% (up 2.0% YoY) and the FY2025 annual result came in at 35.01%, down 339.0% from the prior year.
- EBIT Margin declined to 41.35% in Q1 2026, from 27.46% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 0.86% in Q1 2022 to a low of 47.31% in Q3 2023.
- A 5-year average of 28.77% and a median of 32.31% in 2024 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2023 — EBIT Margin slumped 4345 bps — and 2024, when it soared 1201 bps.
- Tracing FOCL's EBIT Margin over 5 years: stood at 9.99% in 2022, then slumped by 78 bps to 17.75% in 2023, then retreated by 4 bps to 18.4% in 2024, then tumbled by 49 bps to 27.46% in 2025, then plunged by 51 bps to 41.35% in 2026.
- The last three EBIT Margin figures came in at 41.35% (Q1 2026), 27.46% (Q4 2025), and 35.49% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.25% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 1.32% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 1.14% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 4.95% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -60.84% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -5.73% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -0.84% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -15.41% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -6.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.35% |
| Dec 31, 2025 | -27.46% |
| Sep 30, 2025 | -35.49% |
| Jun 30, 2025 | -35.96% |
| Mar 31, 2025 | -44.21% |
| Dec 31, 2024 | -18.40% |
| Sep 30, 2024 | -44.54% |
| Jun 30, 2024 | -38.93% |
| Mar 31, 2024 | -32.31% |
| Dec 31, 2023 | -17.75% |
| Sep 30, 2023 | -47.31% |
| Jun 30, 2023 | -29.58% |
| Mar 31, 2023 | -44.31% |
| Dec 31, 2022 | -9.99% |
| Sep 30, 2022 | -17.55% |
| Jun 30, 2022 | -3.04% |
| Mar 31, 2022 | -0.86% |
| Dec 31, 2021 | 3.30% |
| Sep 30, 2021 | -19.97% |
| Jun 30, 2021 | -4.12% |